BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khalid U, Vi C, Henri J, Macdonald J, Eu P, Mandarano G, Shigdar S. Radiolabelled Aptamers for Theranostic Treatment of Cancer. Pharmaceuticals (Basel) 2018;12:E2. [PMID: 30586898 DOI: 10.3390/ph12010002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Il'in VA, Pyzhik EV, Balakhonov AB, Kiryushin MA, Shcherbatova EV, Kuznetsov AA, Kostin PA, Golovin AV, Korshun VA, Brylev VA, Sapozhnikova KA, Kopylov AM, Pavlova GV, Pronin IN. Radiochemical Synthesis of 4-[(18)F]FluorobenzylAzide and Its Conjugation with EGFR-Specific Aptamers. Molecules 2022;28. [PMID: 36615487 DOI: 10.3390/molecules28010294] [Reference Citation Analysis]
2 Nuzzo S, Iaboni M, Ibba ML, Rienzo A, Musumeci D, Franzese M, Roscigno G, Affinito A, Petrillo G, Quintavalle C, Ciccone G, Esposito CL, Catuogno S. Selection of RNA aptamers targeting hypoxia in cancer. Front Mol Biosci 2022;9:956935. [DOI: 10.3389/fmolb.2022.956935] [Reference Citation Analysis]
3 Togo N, Murase H, Lee J, Taniguchi Y, Sasaki S. Application of the Functionality Transfer Oligodeoxynucleotide for the Site-Selective Modification of RNA with a Divers Molecule. Chem Pharm Bull (Tokyo) 2022;70:498-504. [PMID: 35786569 DOI: 10.1248/cpb.c22-00288] [Reference Citation Analysis]
4 Xu T, Jia F, Cui H, Li M, Li F, Zhang X, Zuo X. Engineering Nucleic Acid Functional Probes in Neuroimaging. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116651] [Reference Citation Analysis]
5 Cohen PF, de Godoy TRM, Kairemo K. Moving Forward: Expected Opportunities for the Development of New Therapeutic Agents. Nuclear Medicine and Immunology 2022. [DOI: 10.1007/978-3-030-81261-4_21] [Reference Citation Analysis]
6 Ozerskaya AV, Zamay TN, Kolovskaya OS, Tokarev NA, Belugin KV, Chanchikova NG, Badmaev ON, Zamay GS, Shchugoreva IA, Moryachkov RV, Zabluda VN, Khorzhevskii VA, Shepelevich N, Gappoev SV, Karlova EA, Saveleva AS, Volzhentsev AA, Blagodatova AN, Lukyanenko KA, Veprintsev DV, Smolyarova TE, Tomilin FN, Zamay SS, Silnikov VN, Berezovski MV, Kichkailo AS. 11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography. Molecular Therapy - Nucleic Acids 2021;26:1159-1172. [DOI: 10.1016/j.omtn.2021.10.020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Vi C, Mandarano G, Shigdar S. Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach. Int J Mol Sci 2021;22:6163. [PMID: 34200484 DOI: 10.3390/ijms22116163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Amero P, Khatua S, Rodriguez-Aguayo C, Lopez-Berestein G. Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology. Cancers (Basel) 2020;12:E2889. [PMID: 33050158 DOI: 10.3390/cancers12102889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Filippi L, Bagni O, Nervi C. Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer. Expert Rev Med Devices 2020;17:751-8. [PMID: 32669004 DOI: 10.1080/17434440.2020.1796633] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Shigdar S. Aptamer-Based Diagnostics and Therapeutics. Pharmaceuticals (Basel) 2019;12:E6. [PMID: 30609700 DOI: 10.3390/ph12010006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]